#news #biotech Rigel falsely claims FDA approval in ‘website error’

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Rigel falsely claims FDA approval in ‘website error’ .Rigel Pharmaceuticals has falsely claimed its chronic immune thrombocytopenia drug Tavalisse is FDA approved. The erroneous claim was up on Rigel’s website for more than 24 hours before a spike in the company’s stock raised awareness of the mistake.

from FierceBiotech: Biotech https://ift.tt/2Hxqkgi